Radiotherapy Plus ADT Seen to Improve Survival in Advanced Prostate Cancers

Radiotherapy Plus ADT Seen to Improve Survival in Advanced Prostate Cancers
Combining prostate radiotherapy with standard-of-care androgen deprivation therapies (ADT) significantly prolongs survival in patients newly diagnosed with metastatic prostate cancer, according to a recent study at the University of Colorado School of Medicine. The study, “Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer,” published in the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *